Congenital Heart Surgeons' Society
CHSS Home CHSS Home Past & Future Meetings Past & Future Meetings

Back to 2023 Abstracts


Outcomes Of Heart Transplantation In Children With Heterotaxy Syndrome
Jaimin Trivedi, Sarah Wilkens, Andrea Nicole Lambert, Deborah Kozik, Bahaaldin Alsoufi.
University of Louisville, Louisville, KY, USA.

Objectives: End-stage congenital heart disease (CHD) in children with heterotaxy (HTX) might necessitate heart transplantation (HT). HT for HTX can be associated with several technical (multi-redo, systemic/pulmonary-venous/situs anomalies, PA reconstruction), and extra-cardiac (ciliary dyskinesia, infections, GI) challenges. We aim to examine if HTX is associated with increased early or late HT risks. Methods: The UNOS transplantation database was merged with PHIS administrative database to identify HT children with HTX. Characteristics and outcomes were compared between HTX (n=143) and contemporaneous CHD (n=428) and cardiomyopathy (CMP, n=551) control groups. Results: There were differences in characteristics between the 3 groups, with HTX being comparable to CHD. [Table] The waitlist duration was higher for HTX than CHD and CMP (91 vs. 63 vs. 56 days,p<0.1). Early post-HT complications were similar for all groups except for operative mortality that was 1% for CMP and 4% for CHD and HTX,p<0.1. Post-HT stay was shorter for CMP (57) compared to CHD (99) and HTX (89) days,p<0.1. While rejection before discharge was comparable between groups, 1-year rejection was higher for HTX (22%), than CHD (19%) and CMP (13%),p<0.1. Survival at 5-years was superior for CMP (91%) than CHD (82%) and HTX (81%),p<0.1. On multivariable analysis, no risk factors were identified for HTX group. Conclusion: HT in children with HTX is associated with good outcomes that are comparable to those with other forms of CHD.


Back to 2023 Abstracts